English
Specials
Go Ad-Free
My Alerts
Moneycontrol
Moneycontrol PRO
Get App Open
In App Credit Cards
Go PRO Now
Open App
you are here:
MARKETS

Dr Lal PathLabs Ltd.

BSE: 539524 | NSE: LALPATHLAB |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE600L01024 | SECTOR: Hospital & Healthcare Services

| BSE 3310.95 -18.50 (-0.56%) | |

BSE Live

Sep 24, 16:01
3310.95 -18.50 (-0.56%)
Volume
AVERAGE VOLUME
5-Day
11,006
10-Day
6,546
30-Day
5,322
1,073

  • Prev. Close

    3329.45

  • Open Price

    3335.70

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Sep 24, 15:55
3304.40 -25.90 (-0.78%)
Volume
AVERAGE VOLUME
5-Day
174,612
10-Day
136,894
30-Day
138,049
164,224

  • Prev. Close

    3330.30

  • Open Price

    3330.30

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    3304.40 (2)

Financials

Cash Flow of Dr Lal PathLabs (in Rs. Cr.) Mar 15  
  12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 139.72  
Net CashFlow From Operating Activities 121.77  
Net Cash Used In Investing Activities -113.45  
Net Cash Used From Financing Activities -0.80  
Foreign Exchange Gains / Losses 0.00  
Adjustments On Amalgamation Merger Demerger Others 0.00  
Net Inc/Dec In Cash And Cash Equivalents 7.52  
Cash And Cash Equivalents Begin of Year 15.76  
Cash And Cash Equivalents End Of Year 23.28  
Source : Dion Global Solutions Limited

Results of Dr Lal PathLab

Results of Pharmaceuticals Sector

Quick links

News

Corporate Action

Information

Financials

Annual Report

Peer Comparison

Related Searches

Dr Lal PathLabs Stock Price | Dr Lal PathLab Stock Quote | Dr Lal PathLab Results | Dr Lal PathLab News | View All Related Searches
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347